GGU’s New Master’s Degree in Business Analytics Prepares Students for Lucrative Big Data Careers
Jan 05, 2017 22:00 pm UTC| Business
SAN FRANCISCO, Jan. 05, 2017 -- Golden Gate University (GGU) is now accepting applications for a new master’s degree in Business Analytics (MSBA), which focuses on the application of data analytics to solve real-world...
Mitel to Present at the 19th Annual Needham Growth Conference
Jan 05, 2017 21:43 pm UTC| Business
OTTAWA, Jan. 05, 2017 -- Mitel® (Nasdaq:MITL) (TSX:MNW), a global leader in real-time business communications, today announced that its management team will beparticipating at the 19th Annual Needham Growth Conference...
Kinsale’s Public Entity Division Introduces Educational Institution Liability Coverage
Jan 05, 2017 21:36 pm UTC| Business
RICHMOND, Va., Jan. 05, 2017 -- Kinsale Insurance Company (Kinsale), a subsidiary of Kinsale Capital Group, Inc. (NASDAQ:KNSL), announced it is now offering Educational Institution (School Board) Liability Coverage...
Furkids Video Reaches Millions
Jan 05, 2017 21:30 pm UTC| Business
ATLANTA, Jan. 05, 2017 -- An improvised video clip using humor and satire to urge people to adopt homeless animals at Atlanta-based Furkids Animal Rescue and Shelters has taken social media by storm. In spoofing a TV...
Jan 05, 2017 21:30 pm UTC| Business
Ongoing Phase 2 trial with additional small cohort (8-12 patients planned) sufficient for BLA filing for full approval Approximately half of new cohort patients already enrolled, with full enrollment expected this...
Clearside Biomedical, Inc. Receives Notice of Allowance for Seventh U.S. Patent
Jan 05, 2017 21:30 pm UTC| Business
ALPHARETTA, Ga., Jan. 05, 2017 -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, today announced it has...
MacroGenics’ MGD006 Granted Orphan Drug Status for AML by FDA
Jan 05, 2017 21:30 pm UTC| Business
ROCKVILLE, MD, Jan. 05, 2017 -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment...